Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”

Jignesh P. Patel; Vassan Thavarajah; Lara N. Roberts

doi:10.1016/j.rpth.2023.100172

Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”

Jignesh P. Patel^*, Vassan Thavarajah, Lara N. Roberts

^*Corresponding author for this work

Institute of Pharmaceutical Science

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	100172
Number of pages	2
Journal	Research and practice in thrombosis and haemostasis
Volume	7
Issue number	4
Early online date	9 May 2023
DOIs	https://doi.org/10.1016/j.rpth.2023.100172
Publication status	E-pub ahead of print - 9 May 2023

Access to Document

10.1016/j.rpth.2023.100172Licence: CC BY-NC-ND

Cite this

Patel, J. P., Thavarajah, V., & Roberts, L. N. (2023). Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”. Research and practice in thrombosis and haemostasis, 7(4), Article 100172. Advance online publication. https://doi.org/10.1016/j.rpth.2023.100172

@article{076bb35d2b03441ea371a330d12f4b5b,

title = "Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”",

author = "Patel, {Jignesh P.} and Vassan Thavarajah and Roberts, {Lara N.}",

note = "Funding Information: There are no competing interests to disclose. The authors received no funding for this study.",

year = "2023",

month = may,

day = "9",

doi = "10.1016/j.rpth.2023.100172",

language = "English",

volume = "7",

journal = "Research and practice in thrombosis and haemostasis",

issn = "2475-0379",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "4",

}

Patel, JP, Thavarajah, V & Roberts, LN 2023, 'Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”', Research and practice in thrombosis and haemostasis, vol. 7, no. 4, 100172. https://doi.org/10.1016/j.rpth.2023.100172

Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”. / Patel, Jignesh P.; Thavarajah, Vassan; Roberts, Lara N.
In: Research and practice in thrombosis and haemostasis, Vol. 7, No. 4, 100172, 09.05.2023.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”

AU - Patel, Jignesh P.

AU - Thavarajah, Vassan

AU - Roberts, Lara N.

N1 - Funding Information: There are no competing interests to disclose. The authors received no funding for this study.

PY - 2023/5/9

Y1 - 2023/5/9

UR - http://www.scopus.com/inward/record.url?scp=85160760528&partnerID=8YFLogxK

U2 - 10.1016/j.rpth.2023.100172

DO - 10.1016/j.rpth.2023.100172

M3 - Letter

AN - SCOPUS:85160760528

SN - 2475-0379

VL - 7

JO - Research and practice in thrombosis and haemostasis

JF - Research and practice in thrombosis and haemostasis

IS - 4

M1 - 100172

ER -

Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”

Access to Document

Other files and links

Cite this